Open AccessInfluence of Age on Outcomes in HIV-Infected Adults Initiating Tenofovir Alafenamide Fumarate (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F/TAF versus E/C/F/TDF)
Author(s) -
Eric S. Daar,
Michael S. Saag,
Benoît Trottier,
Amanda Clarke,
Edwin DeJesus,
David Parks,
Eugénio Teófilo,
Cynthia Brinson,
Hal Martin,
Susan Guo,
Sandra Friborg,
Marshall W. Fordyce
Publication year - 2015
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv133.787
Subject(s) - elvitegravir , tenofovir alafenamide , cobicistat , emtricitabine , medicine , human immunodeficiency virus (hiv) , tenofovir , virology , viral load , antiretroviral therapy